SGYP - Seeking Alpha - Ironwood's Future Outlook And Uncertainty Jun. 26, 2017 12:59 PM • IRWD >Trulance is approaching over 1,300 prescriptions per week, with 52% said to be OTC growth and 48% from ex-Linzess patients or Amitiza.< https://seekingalpha.com/article/4083949-ironwoods-future-outlook-uncertainty